Head-to-head · WeighScore
Noom Med vs NowPatient
The verdict
Noom Med takes it — 68.3/100 to 65.5/100.
Noom Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Noom Med integrates GLP-1 medication access with Noom's proven cognitive behavioral therapy curriculum, 1-on-1 dietitian coaching, and dedicated care team — the most comprehensive psychology-plus-medication…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Noom Med | NowPatient |
|---|---|---|
| WeighScore | 68.3/100 | 65.5/100 |
| Grade | C | C |
| Scorecard rank | #155 | #222 |
| Semaglutide | Not disclosed | $1,349/mo (brand Wegovy) |
| Tirzepatide | Not disclosed | $1,069/mo (brand Mounjaro, promotional rate) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #155 · C
Strengths
- Combines GLP-1 medication with CBT behavior change
- Dedicated dietitian included in every plan
- Highest support score in fitness app category
- Integrated care team for medication and coaching
- Noom's proven behavioral curriculum
Where it loses points
- Available in only 40 states — excludes AK, HI, ID, MT, NM, SD, VT, WV, WY, ND
- More expensive than app-only alternatives
- Requires commitment to both medication and coaching program
Graded #222 · C
Strengths
- Free telehealth consultation — you only pay for the medication
- Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- One of the few platforms offering Wegovy in both injection and oral pill form
- No compounded options — every drug is FDA-approved brand-name
Where it loses points
- Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
- No compounded semaglutide or tirzepatide (usually the cheaper route)
- State availability determined during intake, not shown upfront
- Does not offer Foundayo (orforglipron)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.